To view this email as a web page, click here.
 
PHARMACISTS' REPORT
Avatrombopag for Thrombocytopenia in Adults
Our latest New Drug Review covers Dova's most recent medication.
Read more
 
ADVERTISEMENT
 
Will 340B Cuts Affect Clinical Outcomes?
CMS made significant cuts to its drug pricing program, impacting hospitals and patients alike.
Read more
 
The Worst Pharmacy Bosses of All Time
Some of the worst people you've ever had to deal with in the pharmacy.
Read more
 
Declining Pharmacy School Enrollment, High Drug Prices, and More News
The latest Small Doses, news for the busy pharmacist.
Read more
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.